Annual Revenue
$1.80 M
+$304.80 K+20.44%
December 1, 2023
Summary
- As of February 7, 2025, ADXN annual revenue is $1.80 million, with the most recent change of +$304.80 thousand (+20.44%) on December 1, 2023.
- During the last 3 years, ADXN annual revenue has fallen by -$2.06 million (-53.39%).
- ADXN annual revenue is now -92.76% below its all-time high of $24.82 million, reached on December 31, 2008.
Performance
ADXN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$62.30 K
-$65.20 K-51.14%
September 1, 2024
Summary
- As of February 7, 2025, ADXN quarterly revenue is $62.30 thousand, with the most recent change of -$65.20 thousand (-51.14%) on September 1, 2024.
- Over the past year, ADXN quarterly revenue has dropped by -$308.80 thousand (-83.21%).
- ADXN quarterly revenue is now -96.91% below its all-time high of $2.01 million, reached on December 31, 2020.
Performance
ADXN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$630.00 K
-$308.80 K-32.89%
September 1, 2024
Summary
- As of February 7, 2025, ADXN TTM revenue is $630.00 thousand, with the most recent change of -$308.80 thousand (-32.89%) on September 1, 2024.
- Over the past year, ADXN TTM revenue has dropped by -$1.60 million (-71.74%).
- ADXN TTM revenue is now -86.82% below its all-time high of $4.78 million, reached on September 30, 2021.
Performance
ADXN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ADXN Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.4% | -83.2% | -71.7% |
| 3 y3 years | -53.4% | -85.5% | -80.3% |
| 5 y5 years | -70.9% | -87.8% | -77.4% |
ADXN Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -43.7% | +20.4% | -91.1% | at low | -80.3% | at low |
| 5 y | 5-year | -53.4% | +20.4% | -96.9% | +110.5% | -86.8% | at low |
| alltime | all time | -92.8% | +342.3% | -96.9% | +110.5% | -86.8% | at low |
Addex Therapeutics Ltd Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $62.30 K(-51.1%) | $630.00 K(-32.9%) |
| Jun 2024 | - | $127.50 K(-52.3%) | $938.80 K(-38.0%) |
| Mar 2024 | - | $267.10 K(+54.3%) | $1.51 M(-15.3%) |
| Dec 2023 | $1.80 M(+20.4%) | $173.10 K(-53.4%) | $1.79 M(-19.9%) |
| Sep 2023 | - | $371.10 K(-47.1%) | $2.23 M(-2.3%) |
| Jun 2023 | - | $701.90 K(+29.8%) | $2.28 M(+28.9%) |
| Mar 2023 | - | $540.90 K(-12.1%) | $1.77 M(+19.1%) |
| Dec 2022 | $1.49 M(-53.3%) | $615.70 K(+45.2%) | $1.49 M(+14.2%) |
| Sep 2022 | - | $423.90 K(+123.1%) | $1.30 M(-19.7%) |
| Jun 2022 | - | $190.00 K(-26.0%) | $1.62 M(-35.7%) |
| Mar 2022 | - | $256.80 K(-40.4%) | $2.52 M(-21.2%) |
| Dec 2021 | $3.19 M(-17.2%) | $431.20 K(-42.0%) | $3.20 M(-33.1%) |
| Sep 2021 | - | $742.90 K(-31.8%) | $4.78 M(+17.5%) |
| Jun 2021 | - | $1.09 M(+16.8%) | $4.07 M(+5.1%) |
| Mar 2021 | - | $933.30 K(-53.7%) | $3.87 M(-0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $3.85 M(+38.6%) | $2.01 M(+6705.7%) | $3.87 M(+33.1%) |
| Sep 2020 | - | $29.60 K(-96.7%) | $2.91 M(-14.2%) |
| Jun 2020 | - | $893.20 K(-4.4%) | $3.39 M(+12.5%) |
| Mar 2020 | - | $934.30 K(-11.1%) | $3.01 M(+8.3%) |
| Dec 2019 | $2.78 M(-55.0%) | $1.05 M(+106.1%) | $2.78 M(+60.7%) |
| Sep 2019 | - | $509.90 K(-1.6%) | $1.73 M(+41.7%) |
| Jun 2019 | - | $518.00 K(-26.4%) | $1.22 M(+73.6%) |
| Mar 2019 | - | $703.40 K | $703.40 K |
| Dec 2018 | $6.18 M(+93.3%) | - | - |
| Dec 2011 | $3.20 M(+69.4%) | - | - |
| Dec 2010 | $1.89 M(-50.1%) | - | - |
| Dec 2009 | $3.78 M(-84.8%) | - | - |
| Dec 2008 | $24.82 M(+6011.1%) | - | - |
| Dec 2007 | $406.10 K(-89.3%) | - | - |
| Dec 2006 | $3.78 M | - | - |
FAQ
- What is Addex Therapeutics Ltd annual revenue?
- What is the all time high annual revenue for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd annual revenue year-on-year change?
- What is Addex Therapeutics Ltd quarterly revenue?
- What is the all time high quarterly revenue for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly revenue year-on-year change?
- What is Addex Therapeutics Ltd TTM revenue?
- What is the all time high TTM revenue for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd TTM revenue year-on-year change?
What is Addex Therapeutics Ltd annual revenue?
The current annual revenue of ADXN is $1.80 M
What is the all time high annual revenue for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high annual revenue is $24.82 M
What is Addex Therapeutics Ltd annual revenue year-on-year change?
Over the past year, ADXN annual revenue has changed by +$304.80 K (+20.44%)
What is Addex Therapeutics Ltd quarterly revenue?
The current quarterly revenue of ADXN is $62.30 K
What is the all time high quarterly revenue for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high quarterly revenue is $2.01 M
What is Addex Therapeutics Ltd quarterly revenue year-on-year change?
Over the past year, ADXN quarterly revenue has changed by -$308.80 K (-83.21%)
What is Addex Therapeutics Ltd TTM revenue?
The current TTM revenue of ADXN is $630.00 K
What is the all time high TTM revenue for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high TTM revenue is $4.78 M
What is Addex Therapeutics Ltd TTM revenue year-on-year change?
Over the past year, ADXN TTM revenue has changed by -$1.60 M (-71.74%)